News Jushi Holdings Inc. Amends and Refiles Q1 2022 Financial Statements Staff June 25, 2022 Iframe sync Post navigation Previous: Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – UpdateNext: Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™ More Stories Antimicrobial Brain News Pregnancy Kirkman(R) Unveils Revolutionary L Reuteri: a Brain-Protective Probiotic with Immune Benefits Staff February 2, 2026 Clinical Trial Diagnostics EHR Genetic Testing Healthcare Hospitals News Pharmaceutical Telemedicine IoT in Healthcare Market to Reach US$594.5 Bn by 2035 at 23.85% CAGR | Vantage Market Research Staff February 2, 2026 Epidemics Healthcare Hospitals Medicaid Medicare News Nursing Pharmaceutical NHI Announces $105.5 Million SHOP Investment Staff February 2, 2026
